Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Wuxi Cancer Intelligent raises over 100 million yuan in Series A+ led by Huatai Zijing. The robot joint module manufacturer plans to scale production to 1 million sets by 2027.
Amount Raised
¥100 Million
Round Type
Series A
Wuxi CityRoboticsInvestors
Description
Wuxi Cancer Intelligent, a core component manufacturer of integrated robot joints, closed a Series A+ round exceeding 100 million yuan led by Huatai Zijing. Follow-up investors include Dechang Motor, Ninebot Capital, and Zibianliang Robot, with existing shareholders Ecovacs and Southern Venture Capital increasing their stakes. The company plans to reach production capacity of 200,000 joint module sets in 2026, scaling to 1 million sets in 2027. This financing reflects the growing trend of humanoid robot companies investing in upstream components while raising capital.
Fundz sees it the moment Wuxi Cancer Intelligent raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansWuxi Cancer Intelligent raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.